Takeda Gets Go-Ahead To Appeal Actos Rulings At 2nd Circ.
A New York federal judge has given pharmaceutical firm Takeda permission to appeal to the Second Circuit two decisions that preserved allegations it delayed the entry of generic alternatives to diabetes...To view the full article, register now.
Already a subscriber? Click here to view full article